FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Caterina Gori

Research Profile

Physiology

Disorders

HIV Infections

Living Beings

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Valentina Svicher; Giuliano Rizzardini; Gabriella Rozera; Maria Mercedes Santoro; Isabella Abbate; Massimo Andreoni; Andrea Antinori; Daniele Armenia; Alessandro Bruselles; Maria Rosaria Capobianchi; Francesca Ceccherini-Silberstein; Valeria Cento; Lavinia Fabeni; Federica Forbici; Caterina Gori; Giuseppe Ippolito; Alessandra Latini; Valeria Micheli; Guido Palamara; Carlo Federico Perno
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.
Maria Mercedes Santoro; Valerio Tozzi; Margriet Van Houtte; Ubaldo Visco-Comandini; Mauro Zaccarelli; Luigi Ronga; Romina Salpini; Claudia Alteri; Andrea Antinori; Ada Bertoli; Evangelo Boumis; Francesca Ceccherini-Silberstein; Roberta D'Arrigo; Lavinia Fabeni; Philippe Flandre; Federica Forbici; Caterina Gori; Fabio Mercurio; Pasquale Narciso; Guido Palamara; Theresa Pattery; Carlo Federico Perno
Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.
M M Santoro; M Surdo; Valentina Svicher; M Santoro; M Andreoni; G Angarano; A Antinori; Daniele Armenia; E Balestra; A Bertoli; Francesca Ceccherini-Silberstein; Luca Dori; L Fabeni; Federica Forbici; E Girardi; Caterina Gori; Pasquale Narciso; Guido Palamara; C F Perno
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Caterina Gori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Valentina Svicher; Giuliano Rizzardini; Gabriella Rozera; Maria Mercedes Santoro; Isabella Abbate; Massimo Andreoni; Andrea Antinori; Daniele Armenia; Alessandro Bruselles; Maria Rosaria Capobianchi; Francesca Ceccherini-Silberstein; Valeria Cento; Lavinia Fabeni; Federica Forbici; Caterina Gori; Giuseppe Ippolito; Alessandra Latini; Valeria Micheli; Guido Palamara; Carlo Federico Perno
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.
PloS one 2013;8(1):e53603.
2012: Maria Mercedes Santoro; Valerio Tozzi; Margriet Van Houtte; Ubaldo Visco-Comandini; Mauro Zaccarelli; Luigi Ronga; Romina Salpini; Claudia Alteri; Andrea Antinori; Ada Bertoli; Evangelo Boumis; Francesca Ceccherini-Silberstein; Roberta D'Arrigo; Lavinia Fabeni; Philippe Flandre; Federica Forbici; Caterina Gori; Fabio Mercurio; Pasquale Narciso; Guido Palamara; Theresa Pattery; Carlo Federico Perno
Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.
AIDS research and human retroviruses 2012;28(10):1285-93.
2012: M M Santoro; M Surdo; Valentina Svicher; M Santoro; M Andreoni; G Angarano; A Antinori; Daniele Armenia; E Balestra; A Bertoli; Francesca Ceccherini-Silberstein; Luca Dori; L Fabeni; Federica Forbici; E Girardi; Caterina Gori; Pasquale Narciso; Guido Palamara; C F Perno
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012;18(8):E289-98.
2011: Valentina Svicher; Pascale Trimoulet; Jens Verheyen; Michela Visca; Linda Wittkop; Xin Xin Zhang; Sara Romano; Romina Salpini; Mario Angelico; Bastian Beggel; Ada Bertoli; Giuseppina Cappiello; Francesca Ceccherini-Silberstein; Valeria Cento; Giuseppe Maria De Sanctis; Hervè Fleury; Maria Fraune; Valentina Gallinaro; Caterina Gori; Guido Gubertini; Yue Han; Roberta Longo; Nicoletta Marino; Francesco Mazzotta; Fabio Mercurio; Valeria Micheli; Carlo Federico Perno
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(12):975-83.
2011: R Salpini; Cesare Sarrecchia; F Scopelliti; A Spanò; Valentina Svicher; G Rizzardini; Mario Angelico; A Bertoli; T Cappiello; V Cento; G M De Sanctis; Caterina Gori; Valeria Micheli; Carlo Federico Perno
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
Antiviral research 2011;92(2):382-5.
2011: Claudia Alteri; Andrea Antinori; Barbara Bartolini; Alessandro Bruselles; Maria Rosaria Capobianchi; Francesca Ceccherini-Silberstein; Federica Forbici; Enrico Girardi; Caterina Gori; Pasquale Narciso; Nicoletta Orchi; Guido Palamara; Gabriella Rozera; Maria Mercedes Santoro; Valentina Svicher; Valerio Tozzi; Isabella Abbate; Carlo Federico Perno
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.
The Journal of antimicrobial chemotherapy 2011;66(11):2615-23.
2011: J Fokam; Caterina Gori; L C Gwom; Aubin Nanfack; Carlo Federico Perno; R Salpini; M M Santoro; giulia cappelli; V Cento; V Colizzi; Roberta D'Arrigo; D Takou
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.
Archives of virology 2011;156(7):1235-43.
2010: Valentina Svicher; Claudia Alteri; Caterina Gori; Romina Salpini; Fabbio Marcuccilli; Ada Bertoli; Roberta Longo; Martina Bernassola; Valentina Gallinaro; Sara Romano; Michela Visca; Antonella Ursitti; Marcello Feasi; Valeria Micheli; Mario Angelico; Giovanni Cassola; Giustino Parruti; Guido Gubertini; Giuseppe Maria De Sanctis; Francesca Ceccherini-Silberstein; Giuseppina Cappiello; Alberto Spanò; Carlo Federico Perno
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2010;42(12):902-7.
2009: Valentina Svicher; Caterina Gori; Maria Trignetti; Michela Visca; Valeria Micheli; Martina Bernassola; Romina Salpini; Guido Gubertini; Roberta Longo; Fosca Niero; Francesca Ceccherini-Silberstein; Giuseppe Maria De Sanctis; Alberto Spanò; Giuseppina Cappiello; Carlo Federico Perno
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes.
Journal of hepatology 2009;50(3):461-70.
2009: Claudia Alteri; Valentina Svicher; Caterina Gori; Roberta D'Arrigo; Massimo Ciccozzi; Francesca Ceccherini-Silberstein; Marina Selleri; Stefano Aviani Bardacci; Massimo Giuliani; Paola Elia; Paola Scognamiglio; Roberta Balzano; Nicoletta Orchi; Enrico Girardi; Carlo Federico Perno
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.
BMC infectious diseases 2009;9():111.
2008: Valerio Tozzi; Rita Bellagamba; Filippo Castiglione; Alessanda Amendola; Jelena Ivanovic; Emanuele Nicastri; Raffaella Libertone; Gianpiero D'Offizi; Giuseppina Liuzzi; Caterina Gori; Federica Forbici; Roberta D'Arrigo; Ada Bertoli; Maria Flora Salvatori; Maria Rosaria Capobianchi; Andrea Antinori; Carlo Federico Perno; Pasquale Narciso
Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART.
AIDS research and human retroviruses 2008;24(6):787-96.
2007: Roberta D'Arrigo; Massimo Ciccozzi; Caterina Gori; Stefania Montieri; Stefano Aquaro; Rita Bellagamba; Evangelo Boumis; Giovanni Di Perri; Daniele Pizzi; Andrea Antinori; Giovanni Rezza; Carlo Federico Perno
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure.
AIDS research and human retroviruses 2007;23(10):1296-302.
2007: Anna Casabianca; Caterina Gori; Chiara Orlandi; Federica Forbici; Carlo Federico Perno; Mauro Magnani
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay.
Molecular and cellular probes 2007;21(5-6):368-78.
2006: Maria Mercedes Santoro; Valentina Svicher; Caterina Gori; Mauro Zaccarelli; Valerio Tozzi; Federica Forbici; Roberta D'Arrigo; Maria Paola Trotta; Maria Concetta Bellocchi; Ubaldo Visco-Comandini; Alessandra Cenci; Ada Bertoli; Pasquale Narciso; Andrea Antinori; Carlo Federico Perno; Francesca Ceccherini-Silberstein
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.
The new microbiologica 2006;29(2):89-100.
2006: Valerio Tozzi; Mauro Zaccarelli; Sandro Bonfigli; Patrizia Lorenzini; Giuseppina Liuzzi; Maria Paola Trotta; Federica Forbici; Caterina Gori; Ada Bertoli; Rita Bellagamba; Pasquale Narciso; Carlo Federico Perno; Andrea Antinori
Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.
Antiviral therapy 2006;11(5):553-60.
2005: Francesca Ceccherini-Silberstein; Federico Gago; Maria Santoro; Caterina Gori; Valentina Svicher; Fátima Rodríguez-Barrios; Roberta D'Arrigo; Massimo Ciccozzi; Ada Bertoli; Antonella d'Arminio Monforte; Jan Balzarini; Andrea Antinori; Carlo Federico Perno
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations.
Journal of virology 2005;79(16):10718-29.
2005: Massimo Ciccozzi; Caterina Gori; Stefano Boros; Maria Jose Ruiz-Alvarez; Arjan Harxhi; Marjeta Dervishi; Shpetim Qyra; Nicola Schinaia; Roberta D'Arrigo; Francesca Ceccherini-Silberstein; Silva Bino; Carlo Federico Perno; Giovanni Rezza
Molecular diversity of HIV in Albania.
The Journal of infectious diseases 2005;192(3):475-9.
2005: Maria Concetta Bellocchi; Federica Forbici; leonardo Palombi; Caterina Gori; Elisabeth Coelho; Valentina Svicher; Roberta D'Arrigo; Leonardo Emberti Gialloreti; Susanna Ceffa; Fulvio Erba; Maria Cristina Marazzi; Francesca Ceccherini Silberstein; Carlo Federico Perno
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Journal of medical virology 2005;76(4):452-8.
2005: Mauro Zaccarelli; Valerio Tozzi; Patrizia Lorenzini; Maria Paola Trotta; Federica Forbici; Ubaldo Visco-Comandini; Caterina Gori; Pasquale Narciso; Carlo Federico Perno; Andrea Antinori
Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.
AIDS (London, England) 2005;19(10):1081-9.
2005: Valentina Svicher; Francesca Ceccherini-Silberstein; Fulvio Erba; Maria Santoro; Caterina Gori; Maria Concetta Bellocchi; Sara Giannella; Maria Paola Trotta; Antonella d'Arminio Monforte; Andrea Antinori; Carlo Federico Perno
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors.
Antimicrobial agents and chemotherapy 2005;49(5):2015-25.
2004: Francesca Ceccherini-Silberstein; Fulvio Erba; Federico Gago; Ada Bertoli; Federica Forbici; Maria Concetta Bellocchi; Caterina Gori; Roberta D'Arrigo; Luisa Marcon; Claudia Balotta; Andrea Antinori; Antonella d'Arminio Monforte; Carlo Federico Perno
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.
AIDS (London, England) 2004;18(12):F11-9.
2004: Andrea De Luca; Marilena Vendittelli; Francesco Baldini; Simona Di Giambenedetto; Maria Paola Trotta; Antonella Cingolani; Alessandra Bacarelli; Caterina Gori; Carlo Federico Perno; Andrea Antinori; Giovanni Ulivi
Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
Antiviral therapy 2004;9(4):583-93.
2004: Maria Santoro; Francesca Ceccherini-Silberstein; Caterina Gori; Valentina Svicher; Federica Forbici; Maria Concetta Bellocchi; Roberta D'Arrigo; Ada Bertoli; Sara Giannella; Maria Paola Trotta; Sandro Bonfigli; Andrea Antinori; Carlo Federico Perno
Temporal change in the use of genotypic resistance testing over the years 1999--2003.
The new microbiologica 2004;27(2 Suppl 1):141-4.
2004: Mauro Zaccarelli; Carlo Federico Perno; Federica Forbici; Fabio Soldani; Sandro Bonfigli; Caterina Gori; Maria Paola Trotta; Maria Concetta Bellocchi; Giuseppina Liuzzi; Roberta D'Arrigo; Patrizio De Longis; Evangelo Boumis; Rita Bellagamba; Valerio Tozzi; Pasquale Narciso; Andrea Antinori
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(3):433-7.
2003: Bruno Christian Ciancio; Maria Paola Trotta; Patrizia Lorenzini; Federica Forbici; Ubaldo Visco-Comandini; Caterina Gori; Sandro Bonfigli; Maria Concetta Bellocchi; Pietro Sette; Roberta D'Arrigo; Valerio Tozzi; Mauro Zaccarelli; Evangelo Boumis; Pasquale Narciso; Carlo Federico Perno; Andrea Antinori
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.
Antiviral therapy 2003;8(6):611-6.
2003: Mauro Zaccarelli; Carlo Federico Perno; Federica Forbici; Antonella Cingolani; Giuseppina Liuzzi; Ada Bertoli; Maria Paola Trotta; Maria Concetta Bellocchi; Simona Di Giambenedetto; Valerio Tozzi; Caterina Gori; Roberta D'Arrigo; Patrizio De Longis; Pasquale Noto; Enrico Girardi; Andrea De Luca; Andrea Antinori
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
Antiviral therapy 2003;8(1):51-6.
2002: Carlo Federico Perno; Francesca Ceccherini-Silberstein; Andrea De Luca; Alessandro Cozzi-Lepri; Caterina Gori; Antonella Cingolani; Maria Concetta Bellocchi; Maria Paola Trotta; Paola Piano; Federica Forbici; Antonio Scasso; Vincenzo Vullo; Antonella d'Arminio Monforte; Andrea Antinori
Virologic correlates of adherence to antiretroviral medications and therapeutic failure.
Journal of acquired immune deficiency syndromes (1999) 2002;31 Suppl 3():S118-22.